RxDoctor Payments Data

Boris Sepesi, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Englewood, CONPI 1639182785

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (59.5%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. AstraZeneca accounts for 88.7% of it on its own, with 7 other manufacturers making up the rest. 2025 is the largest year on record at $56,529, more than ten times the $40 reported in 2019. Among thoracic surgery (cardiothoracic vascular surgery) clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$112,851in general payments, 2019–2025

Across 72 payments — averaging $1567.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$100K
  • E.r. Squibb & Sons, L.L.C.$11K
  • Astrazeneca UK Limited$2K
  • Medtronic$190
  • BD$162
  • Abiomed$149
  • plus $125 from 2 others
$1,602,534in research payments, 2019–2025

Across 14 payments — averaging $114,467 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AstraZeneca$655K
  • Pfizer$450K
  • Foundation Medicine, Inc.$280K
  • Genentech, Inc.$214K
  • F. Hoffmann-la Roche AG$3K

What the payments were for

  • Consulting fees$67,19960%
  • Speaking & faculty fees$38,08034%
  • Travel & lodging$5,2065%
  • Food & beverage$2,3672%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$112,851 in reported general payments places this provider in the 95th percentile of 72 thoracic surgery (cardiothoracic vascular surgery) providers in Colorado.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Colorado

Medicare billing

Part B allowed, 2024
$59,137
Medicare patients
76
Services billed
163

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other thoracic surgery (cardiothoracic vascular surgery) in Englewood

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →